Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma.
Chang YH, Yu CH, Lu MY, Jou ST, Lin CY, Lin KH, Chang HH, Ni YL, Chou SW, Ko KY, Lin DT, Hsu WM, Chen HY, Yang YL.
Chang YH, et al. Among authors: chou sw.
Pediatr Blood Cancer. 2024 Sep;71(9):e31176. doi: 10.1002/pbc.31176. Epub 2024 Jul 5.
Pediatr Blood Cancer. 2024.
PMID: 38967585